Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-065414

bluebird bio, Inc. · BLUE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Jeffrey T. Walsh
Officer — Chief Financial · Other
Period of report
Dec 11, 2017
Accepted (ET)
Dec 13, 2017 · 4:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockDec 11, 2017M9,900$24.47A37,205D
Common StockF2Dec 11, 2017S1,299$210.2482D35,906D
Common StockF3Dec 11, 2017S101$211.0594D35,805D
Common StockF4Dec 11, 2017S1,200$212.7004D34,605D
Common StockF5Dec 11, 2017S520$213.6462D34,085D
Common StockF6Dec 11, 2017S380$214.5842D33,705D
Common StockF7Dec 11, 2017S2,550$217.3318D31,155D
Common StockF8Dec 11, 2017S950$218.0895D30,205D
Common StockF9Dec 11, 2017S800$219.4855D29,405D
Common StockF10Dec 11, 2017S680$220.5206D28,725D
Common StockF11Dec 11, 2017S1,420$221.5169D27,305D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (right to buy)F12$24.47Dec 11, 2017M9,900D—Mar 3, 2024Common Stock9,90032,271D

Explanation of responses